# Exercise Stress Testing in Clinical Cardiology: A Practical Guide to Performance and Interpretation

**Authors:** Chiara Carluccio, Francesco Bressan, Matteo Pizzolato, Amedeo De Antoni, Simone Ungaro, Dorottya Balla, Alberto Cipriani, Manuel De Lazzari, Martina Perazzolo Marra, Hajnalka Vago, Domenico Corrado, Alessandro Zorzi, Francesca Graziano

PMC · DOI: 10.3390/jcm15041656 · Journal of Clinical Medicine · 2026-02-22

## TL;DR

Exercise stress testing is a valuable and cost-effective diagnostic tool in cardiology that helps assess heart function, arrhythmias, and device performance during physical activity.

## Contribution

This paper provides a practical guide for performing and interpreting exercise stress tests with a focus on arrhythmic and hemodynamic findings.

## Key findings

- Exercise stress testing helps evaluate exercise-induced arrhythmias and ion channel diseases.
- The test is useful for assessing device function and conduction disorders like Wolff–Parkinson–White syndrome.
- Illustrative clinical cases are included to aid in the interpretation of test results.

## Abstract

Exercise stress testing remains one of the most widely used and cost-effective diagnostic tools in clinical cardiology. Beyond the traditional evaluation of induced ischemia, it provides valuable information on functional capacity, blood pressure response and arrhythmic behavior during exercise. In particular, the test plays a crucial role in assessing and interpreting exercise-induced arrhythmias, including tachyarrhythmias, such as premature ventricular beats (PVBs) and bradyarrhythmias, as well as corroborating the suspicion of some ion channel diseases. The usefulness of exercise testing is also highlighted in patients with devices, where it can help evaluate their function and exercise adaptation, as well as in specific conduction disorders, such as Wolff–Parkinson–White syndrome. This practical guide summarizes the key aspects of performing and interpreting the exercise stress test, focusing on hemodynamic and arrhythmic findings and their clinical implications, and includes several illustrative clinical cases.

## Linked entities

- **Diseases:** Wolff–Parkinson–White syndrome (MONDO:0008685)

## Full-text entities

- **Genes:** KCNJ2 (potassium inwardly rectifying channel subfamily J member 2) [NCBI Gene 3759] {aka ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7}, CALM2 (calmodulin 2) [NCBI Gene 805] {aka CALM, CALML2, CAM1, CAM3, CAMC, CAMII}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, CALM3 (calmodulin 3) [NCBI Gene 808] {aka CALM, CAM1, CAM2, CAMB, CPVT6, CaM}, CASQ2 (calsequestrin 2) [NCBI Gene 845] {aka PDIB2}, TECRL (trans-2,3-enoyl-CoA reductase like) [NCBI Gene 253017] {aka CPVT3, GPSN2L, SRD5A2L2, TERL}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, TRDN (triadin) [NCBI Gene 10345] {aka CARDAR, CPVT5, TDN, TRISK}
- **Diseases:** repolarization abnormalities (MESH:D000014), WPW syndrome (MESH:D014927), death (MESH:D003643), atrial tachycardia (MESH:D013617), hypertension (MESH:D006973), ST-T (MESH:D001260), cardiac output (MESH:D002303), atrial fibrillation (MESH:D001281), ischemic heart disease (MESH:D017202), Ventricular ectopy (MESH:D050030), CV (MESH:D002318), CPVT (MESH:C536334), sudden death (MESH:D003645), myocardial infarction (MESH:D009203), AV conduction abnormalities (MESH:D054537), congenital heart disease (MESH:D006330), hypovolemia (MESH:D020896), AVRT (MESH:D013611), depression (MESH:D003866), heart failure (MESH:D006333), orthopedic, peripheral vascular, or neurological impairments (MESH:D009140), cardiac amyloidosis (MESH:D000686), cardiac disease (MESH:D006331), CAD (MESH:D003324), Chronotropic incompetence (MESH:D001022), cardiac remodeling (MESH:D020257), impaired exercise capacity (MESH:D000092202), CIEDs (MESH:D009471), Ventricular Tachycardia (MESH:D017180), LQTS (MESH:D008133), ventricular fibrillation (MESH:D014693), atherosclerotic plaque (MESH:D058226), -segment (MESH:C537538), LQT1 (MESH:D029597), systolic/diastolic dysfunction (MESH:D054144), Conduction Disorders (MESH:D019955), AV node dysfunction (MESH:D012804), syncope (MESH:D013575), volume overload (MESH:D019190), aortic disease (MESH:D001018), injury to (MESH:D014947), infra-hisian disease (MESH:D004194), coronary disease (MESH:D003327), chronic coronary syndrome (MESH:D054058), ECG (MESH:D053840), pain (MESH:D010146), Sinoatrial Node Dysfunction (MESH:D012848), Atrial-sensed ventricular paced (MESH:D020886), atrioventricular and bundle branch blocks (MESH:D002037), ischemic (MESH:D002545), valvular abnormalities (MESH:D006349), SCD (MESH:C536778), left ventricular pump failure (MESH:D051437), ventricular repolarization abnormalities (MESH:D018754), cardiac channelopathy (MESH:D053447), cardiac arrest (MESH:D006323), angina (MESH:D000787), brady- and tachyarrhythmias (MESH:D013610), Ventricular Arrhythmias (MESH:D001145), ST (MESH:D000072657)
- **Chemicals:** caffeine (MESH:D002110), digitalis glycosides (MESH:D004071), alcohol (MESH:D000438), calcium (MESH:D002118), O2 (MESH:D010100), lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942606/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942606/full.md

## References

127 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942606/full.md

---
Source: https://tomesphere.com/paper/PMC12942606